Impact of the COVID-19 Pandemic on the Severity of Diabetic Ketoacidosis Presentations in a Tertiary Pediatric Emergency Department

Introduction: More severe presentations of diabetic ketoacidosis (DKA) have been reported during the coronavirus disease 2019 (COVID-19) pandemic, possibly due to avoidance of healthcare settings or reduced access to care. To date, no studies have utilized statistical process control to relate temporal COVID-19 events with DKA severity. Our objectives were (1) to determine whether the severity of pediatric DKA presentations changed during COVID-19 and (2) to temporally relate changes in severity with regional pandemic events. Methods: This study was a retrospective chart review of 175 patients younger than 18 years with DKA presenting to a pediatric emergency department in the United States between 5/1/2019 and 8/15/2020. As part of our ongoing clinical standard work in ED management of DKA, DKA severity measures, including presenting pH, the proportion of PICU admissions, and admission length of stay, were analyzed using statistical process control. Results: During COVID-19, we found special cause variation with a downward shift in the mean pH on DKA presentation from 7.2 to 7.1 for all patients. The proportion of DKA patients requiring PICU admission increased from 34.2% to 54.6%. Changes temporally corresponded to the statewide bans on large events (3/11/2020), school closures (3/13/2020), and a reduction in our institution’s emergency department volumes. Admission length of stay was unchanged. Conclusions: Pediatric DKA presentations were more severe from March to June 2020, correlating with regional COVID-19 events. Future quality improvement interventions to reduce delayed presentations during COVID-19 surges or other natural disasters should target accessibility of care and public education regarding the importance of timely care for symptoms.

[1]  I. Altintop,et al.  The Impact of COVID-19 Pandemic on Emergency Department Visits , 2022, Journal of Ankara University Faculty of Medicine.

[2]  A. Zubkiewicz-Kucharska,et al.  Diagnosis of type 1 diabetes during the SARS-CoV-2 pandemic: Does lockdown affect the incidence and clinical status of patients? , 2021, Advances in clinical and experimental medicine : official organ Wroclaw Medical University.

[3]  J. Argente,et al.  Severity in pediatric type 1 diabetes mellitus debut during the COVID-19 pandemic , 2020, Journal of pediatric endocrinology & metabolism : JPEM.

[4]  C. Lawrence,et al.  Increased paediatric presentations of severe diabetic ketoacidosis in an Australian tertiary centre during the COVID‐19 pandemic , 2020, Diabetic medicine : a journal of the British Diabetic Association.

[5]  Kristy L Marynak,et al.  Delay or Avoidance of Medical Care Because of COVID-19–Related Concerns — United States, June 2020 , 2020, MMWR. Morbidity and mortality weekly report.

[6]  D. Barten,et al.  Reduced Emergency Department Utilization During the Early Phase of the COVID-19 Pandemic: Viral Fear or Lockdown Effect? , 2020, Disaster Medicine and Public Health Preparedness.

[7]  I. Rabbone,et al.  Has COVID-19 Delayed the Diagnosis and Worsened the Presentation of Type 1 Diabetes in Children? , 2020, Diabetes Care.

[8]  T. Rohrer,et al.  Ketoacidosis in Children and Adolescents With Newly Diagnosed Type 1 Diabetes During the COVID-19 Pandemic in Germany. , 2020, Journal of the American Medical Association (JAMA).

[9]  E. Codner,et al.  ISPAD Clinical Practice Consensus Guideline: Diabetic ketoacidosis in the time of COVID‐19 and resource‐limited settings‐role of subcutaneous insulin , 2020, Pediatric diabetes.

[10]  T. Chang,et al.  Pediatric Emergency Department Responses to COVID-19: Transitioning From Surge Preparation to Regional Support , 2020, Disaster Medicine and Public Health Preparedness.

[11]  M. McDonnell,et al.  Diabetic Ketoacidosis in COVID-19: Unique Concerns and Considerations , 2020, The Journal of clinical endocrinology and metabolism.

[12]  M. Coletta,et al.  Impact of the COVID-19 Pandemic on Emergency Department Visits — United States, January 1, 2019–May 30, 2020 , 2020, MMWR. Morbidity and mortality weekly report.

[13]  S. Ladhani,et al.  Delayed access to care and late presentations in children during the COVID-19 pandemic: a snapshot survey of 4075 paediatricians in the UK and Ireland , 2020, Archives of Disease in Childhood.

[14]  E. WongLaura,et al.  Where Are All the Patients? Addressing Covid-19 Fear to Encourage Sick Patients to Seek Emergency Care , 2020 .

[15]  N. Riccardi,et al.  Non-COVID-19 visits to emergency departments during the pandemic: the impact of fear , 2020, Public Health.

[16]  S. Garg,et al.  The Silver Lining to COVID-19: Avoiding Diabetic Ketoacidosis Admissions with Telehealth. , 2020, Diabetes technology & therapeutics.

[17]  A. Bauer,et al.  Decline of acute coronary syndrome admissions in Austria since the outbreak of COVID-19: the pandemic response causes cardiac collateral damage , 2020, European heart journal.

[18]  G. Trobia,et al.  Delayed access or provision of care in Italy resulting from fear of COVID-19 , 2020, The Lancet Child & Adolescent Health.

[19]  Atar Baer,et al.  COVID-19 in a Long-Term Care Facility — King County, Washington, February 27–March 9, 2020 , 2020, MMWR. Morbidity and mortality weekly report.

[20]  C. Siu,et al.  Impact of Coronavirus Disease 2019 (COVID-19) Outbreak on ST-Segment–Elevation Myocardial Infarction Care in Hong Kong, China , 2020, Circulation. Cardiovascular quality and outcomes.

[21]  K. Dżygało,et al.  Increased frequency of severe diabetic ketoacidosis at type 1 diabetes onset among children during COVID-19 pandemic lockdown: an observational cohort study. , 2020, Pediatric endocrinology, diabetes, and metabolism.

[22]  Katherine Cashen,et al.  Diabetic Ketoacidosis , 2019, Pediatrics in Review.

[23]  J. Routy,et al.  Clinical outcome after lipectomy in the management of patients with human immunodeficiency virus-associated dorsocervical fat accumulation , 2019, Medicine.

[24]  Ragnar Hanas,et al.  ISPAD Clinical Practice Consensus Guidelines 2018: Diabetic ketoacidosis and the hyperglycemic hyperosmolar state , 2018, Pediatric diabetes.

[25]  W. Rathmann,et al.  Inequalities in glycaemic control, hypoglycaemia and diabetic ketoacidosis according to socio‐economic status and area‐level deprivation in Type 1 diabetes mellitus: a systematic review , 2018, Diabetic medicine : a journal of the British Diabetic Association.

[26]  K. Klee,et al.  Improving Care for Pediatric Diabetic Ketoacidosis , 2014, Pediatrics.

[27]  Lloyd P. Provost,et al.  The Health Care Data Guide: Learning from Data for Improvement , 2011 .

[28]  M. Niedźwiecki,et al.  Difficulties or mistakes in diagnosing type 1 diabetes in children?—demographic factors influencing delayed diagnosis , 2009, Pediatric diabetes.

[29]  J. Kirk,et al.  Delayed diagnosis in type 1 diabetes mellitus , 2008, Archives of Disease in Childhood.

[30]  G. Klingensmith,et al.  455 INCREASED INCIDENCE AND SEVERITY OF DIABETIC KETOACIDOSIS AMONG UNINSURED CHILDREN WITH NEWLY DIAGNOSED TYPE 1 DIABETES , 2005, Journal of Investigative Medicine.

[31]  J. Benneyan,et al.  Statistical process control as a tool for research and healthcare improvement , 2003, Quality & safety in health care.